Subclinical atrial fibrillation and cognitive decline in end stage renal failure
Not Applicable
Recruiting
- Conditions
- Subclinical Atrial FibrillationEnd Stage Renal FailureCognitive DeclineCardiovascular - Other cardiovascular diseasesRenal and Urogenital - Kidney disease
- Registration Number
- ACTRN12622001138774
- Lead Sponsor
- niversity of Adelaide
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
•Participants 18 years or over who have been diagnosed with Chronic Kidney Disease (CKD) for at least three months and are on regular haemodialysis for ESRF.
•Understanding of written and verbal English.
•Ability to provide informed consent.
Exclusion Criteria
•Age < 18 years
•Previously diagnosed AF
•Valvular severe mitral valve disease
•Long-term oral anticoagulant use
•Alzheimers disease
•Aphasia
•Severe psychiatric disorders e.g. schizophrenia, schizoaffective disorder or bipolar disorder
•Pregnancy
•An inability to provide informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome for this study is the prevalence of SCAF in participants with End Stage Renal Failure (ESRF) undergoing haemodialysis. This will be assessed by monitoring six-lead ECGs using the AliveCor Kardia Mobile.[ End of screening for each participant (10 haemodialysis sessions)]
- Secondary Outcome Measures
Name Time Method